Opened in 2009, providing state of the art purpose built facilities, embedded within the Royal Liverpool Hospital which also provides specialist equipment, 24 hour emergency coverage and access to ITU, the CRF offers a safe and regulated environment to perform clinical research trials to the highest possible standards.

With pooled expertise and resources from the neighboring University of Liverpool and the Liverpool School of Tropical Medicine, as well as a strategic alliance with one of the global leaders in early phase drug development (Covance), the CRF offers a wealth of knowledge and experience in pharmaceutical trials.

In addition, with the rapidly expanding databases of volunteers in both healthy and patient populations the CRF is fully equipped to cover all aspects of performing clinical trials from phases I-IV.

All work undertaken in the CRF is underpinned by a strict risk management approval process aligned to policies and procedures which ensure that the quality of both care and research are to the highest standard possible. The CRF has maintained its reputation for excellence, achieving successful inspections according to UK Clinical Trials Legislation and EU Directives, as well as GCP inspections. In 2013 the CRF achieved MHRA supplementary Phase 1 accreditation and was successfully re-accredited in 2015


  • An MHRA Standard and Supplementary Phase 1 Accredited Site
  • Winner - Chairman's Award for Outstanding Performance & Team Work 2011
  • Nominee - Chief Executive Award 2013 ​
  • Winner - Respiratory Team won Chief Executive Award 2016